vincristine
Showing 51 - 75 of 320
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,
Completed
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Pevonedistat
- +7 more
-
Miami, FloridaUniversity of Miami
Oct 19, 2022
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- B Lymphoblastic Lymphoma
- Cyclophosphamide
- +10 more
- (no location specified)
Aug 2, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Milan (NGR-hTNF, RITUXIMAB, Doxorubicin)
Completed
- Lymphoma, Large B-Cell, Diffuse
- NGR-hTNF
- +5 more
-
Milan, ItalyOspedale San Raffaele
Aug 2, 2022
Pleuropulmonary Blastoma Trial in Minneapolis (Vincristine, Dactinomycin, Cyclophosphamide)
Active, not recruiting
- Pleuropulmonary Blastoma
- Vincristine
- +4 more
-
Minneapolis, MinnesotaAnne K Harris
May 26, 2021
Mantle-Cell Lymphoma Trial in Miami (G-CSF, Rituximab, Cyclophosphamide)
Active, not recruiting
- Mantle-Cell Lymphoma
- G-CSF
- +10 more
-
Miami, FloridaUniversity of Miami
Aug 12, 2021
Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)
Completed
- Adult Acute Lymphocytic Leukemia
- Cyclophosphamide
- +20 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 17, 2022
Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)
Recruiting
- Gestational Trophoblastic Neoplasms
- Etoposide
- +7 more
-
Hangzhou, Zhejiang, ChinaWeiguo Lv
Jun 2, 2022
B-cell Lymphoma, Burkitt Lymphoma Trial in Milwaukee (Etoposide, Doxorubicin, Cyclophosphamide)
Not yet recruiting
- B-cell Lymphoma
- Burkitt Lymphoma
- Etoposide
- +8 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jun 11, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)
Recruiting
- Retinoblastoma
- vincristine
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 25, 2022
Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)
Completed
- Acute Lymphoblastic Leukemia
- Everolimus
- +5 more
-
San Francisco, California
- +7 more
Aug 5, 2022
Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)
Completed
- Solid Tumor
- Bevacizumab
- +4 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 8, 2021
Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)
Recruiting
- Relapsed/Refractory Follicular Lymphoma
- Axicabtagene Ciloleucel
- +8 more
-
Denver, Colorado
- +6 more
Dec 2, 2022
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Durvalumab, Rituximab, Doxorubicin)
DLBCL Trial in Cleveland (ME-401, Rituximab, Cyclophosphamide)
Recruiting
- Diffuse Large B-Cell Lymphoma
- ME-401
- +5 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 2, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)
Recruiting
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Rituximab
- +18 more
-
Frankfurt (Main), GermanyUniversity Hospital of Frankfurt (Main)
Jul 1, 2022
T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run
Completed
- T-Cell Peripheral Lymphoma
- +3 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,
Recruiting
- Lymphoblastic Leukemia
- +2 more
- Inotuzumab ozogamicin
- +7 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
May 16, 2022
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Trial in Seattle (procedure, drug, biological)
Not yet recruiting
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
- Bone Marrow Aspiration and Biopsy
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 11, 2022
Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)
Active, not recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +3 more
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Inotuzumab ozogamicin
- +6 more
-
Nashville, Tennessee
- +3 more
Aug 14, 2022
Wilms Tumor Trial in France (Vincristine, Irinotecan, Temozolomide)
Not yet recruiting
- Wilms Tumor
- Vincristine
- +4 more
-
Amiens, France
- +11 more
May 18, 2022
Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)
Recruiting
- Down Syndrome
- +2 more
- Daunorubicin
- +9 more
-
Shatin, New Territories, Hong Kong
- +9 more
Sep 26, 2022